bioequivalence study design of vaginal ring [Design Issues]

posted by Mahesh M – India, 2014-07-16 09:06 (4357 d 20:49 ago) – Posting: # 13272
Views: 5,676

Hi ElMaestro,

That’s nice, actually I work on Ethinyl Estradiol; Etonogestrel (0.015 mg/24 hr; 0.12 mg/24 hr) for US submission.

Dose: single ring for 21 days (Per day ring release 0.015 mg EE and 0.12 mg Etonogestrel) “that mean is like a multiple dose study“ ?

Draft guidance mentioned:

Two way cross over

Bioequivalence based on (90% CI): Ethinyl estradiol and etonogestrel

What is the primary PK parameters ? is it Cmax, AUC0-t and AUC0-∞ or Css (Steady state parameters ) ?

What’s the sampling schedule for this study ?


Regards
Mahesh

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
131 visitors (0 registered, 131 guests [including 27 identified bots]).
Forum time: 05:55 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5